Catherine Vaczy - Feb 4, 2022 Form 4 Insider Report for Genprex, Inc. (GNPX)

Signature
/s/ Catherine Vaczy
Stock symbol
GNPX
Transactions as of
Feb 4, 2022
Transactions value $
$0
Form type
4
Date filed
2/8/2022, 03:43 PM
Next filing
Feb 22, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GNPX Stock Option (right to buy) Award $0 +325K $0.00 325K Feb 4, 2022 Common Stock 325K $2.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option (the "Option") was granted under the Genprex, Inc. (the "Company") 2018 Equity Incentive Plan (the "Plan"). The Option shall vest and become exercisable as to one third (1/3) of the total number of shares (the "Shares") of the Company's common stock, $.001 par value subject to the Option on February 4, 2023 (the "Vesting Commencement Date") and thereafter shall vest and become exercisable as to an additional 1/24 of the remaining Shares subject to the Option on each monthly anniversary of the Vesting Commencement Date until fully vested and exercisable, in each case provided that the Optionee continues to serve as a Service Provider (as defined in the Plan) through the applicable vesting date.